ライフサイエンスコーパス: positive pressure

1 r exhibits a liquid-liquid critical point at positive pressure.

2 ritical point (LLCP) at low temperatures and positive pressures.

3 fluidic artificial muscles that operate with positive pressures.

4 46.8% receiving supplemental oxygen without positive pressure; 11.5% receiving noninvasive ventilati

5 At large positive pressure, a second phase of 2D monolayer ice, i

6 which a spring-loaded air cylinder generates positive pressure and flexible silica capillaries transf

7 activity back to either TRPV4, which sensed positive pressure and stimulated activity, or TRPV1, whi

8 g of water stores, and embolism repair under positive pressure, and providing recommendations for fut

9 Positive pressure applied through the pipette reversibly

10 ct to generate -2.5 cm H(2)O to trigger each positive pressure breath, and (4) added inspiratory resi

11 ubron (n=10) or volume controlled continuous positive pressure breathing (n=8) after acute lung injur

12 tory device failure (mechanical ventilators, positive pressure breathing assist devices, nebulizers,

13 llowing randomization, the volume controlled positive pressure breathing group developed a profound a

14 f the eight animals in the volume controlled positive pressure breathing group were alive at the end

15 unchanged over time in the volume controlled positive pressure breathing group.

16 Animals that received volume controlled positive pressure breathing remained hypoxic with no app

17 comprising the use of suction, intermittent positive-pressure breathing or bronchodilator treatments

18 ntricular stroke volume variation induced by positive-pressure breathing vary in proportion to preloa

19 e sought evidence for insect feeding-induced positive pressure changes in the petioles of Arabidopsis

20 Attempts to recruit lung with positive pressure constitute a major aim in the manageme

21 he pipette had no effect on the channel, but positive pressure could completely and reversibly close

22 onstrate that this extra thrust results from positive pressure created by a vortex ring underneath th

23 opic intubation supported with a noninvasive positive pressure delivery systems may be feasible alter

24 erature-dependent characteristics and weakly positive pressure dependence at low temperatures (e.g.,

25 omenon observed in previous experiments, the positive pressure dependence of the superconducting crit

26 -5 GPa, above which it turns over to normal (positive) pressure dependence.

27 ro, and then revert to normal behaviour with positive pressure dependences.

28 K) at 175 GPa to 11.2 K at 250 GPa, giving a positive pressure derivative of 0.05 K/GPa.

29 During reperfusion, negative and positive pressure derivatives as well as developed press

30 fic indoor air sampling to both negative and positive pressure difference testing can provide insight

31 ce testing and four indoor air exchanges for positive pressure difference testing.

32 gh-contraction ratio, high-output force, and positive pressure-driven X-crossing pneumatic artificial

33 depth depends on achieving a balance between positive pressure effects caused by overburden stress ex

34 quantitative trend observed for hydrostatic positive pressure, exploring the negative pressure regio

35 viral strain, suggesting that the degree of positive pressure for HIV-1 amino acid change is host de

36 ains controversial and is thought to involve positive pressure generated by roots.

37 agm inhibition, esophageal shortening, and a positive pressure gradient between the stomach and the E

38 A positive pressure gradient between the stomach and the E

39 sure group (between -1 and +1 cm H(2)O), and positive pressure group (greater than +1 cm H(2)O).

40 -cell mode of the patch-clamp technique, and positive pressures >=5 mmHg under the cell-attached mode

41 hows that, during locomotion, varanids use a positive pressure gular pump to assist lung ventilation.

42 of high-efficiency particulate air-filtered, positive-pressure Hexapod personal protection booths at

43 s should be conducted with both negative and positive pressure indoor-outdoor differentials of about

44 le alveolus with wavy collagen fibers during positive pressure inflation.

45 When a positive pressure is applied across the bilayer, from th

46 een the laser deflection length and the peak positive pressure is derived.

47 essure (LBNP; -10 mm Hg) and nonhypertensive positive pressure (LBPP; +10 mm Hg) in 11 treated HFrEF

48 (control) or inflated for 15 min (lower body positive pressure [LBPP]) in random order.

49 The experimental results show that the peak positive pressure measured by laser deflection method is

50 plete spinal cord injuries while on constant positive pressure mechanical ventilation (hence, respira

51 rtery pressures attributable to intermittent positive pressure mechanical ventilation formed more ede

52 Positive pressure mechanical ventilation has significant

53 y pressures arising from either intermittent positive pressure mechanical ventilation or from pulsati

54 iratory motor output as follows: (1) passive positive pressure mechanical ventilation, (2) voluntary

55 age than those occurring during intermittent positive pressure mechanical ventilation, suggesting tha

56 stitution of supplemental oxygen therapy and positive pressure mechanical ventilation.

57 Over 30% of critically ill patients on positive-pressure mechanical ventilation have difficulty

58 asible and avoids the deleterious effects of positive-pressure mechanical ventilation in this patient

59 ilure, may compromise the general benefit of positive-pressure-mediated increases in intrapleural pre

60 is an intertwined chronicle of negative and positive pressure modes and their role in managing venti

61 sively and quantitatively measuring the peak positive pressure of HIFU fields.

62 GC interface can be fairly long, because the positive pressure of the carrier gas on the permeate sid

63 At 10 mm Hg positive pressure, peak calcium current increased from -

64 tive higher level of positive end-expiratory positive pressure (PEEP) with alveolar recruitment maneu

65 d with Na-pentobarbital were ventilated by a positive pressure respirator.

66 41.5% [95 of 229]) and the mean (SD) days of positive pressure respiratory support (55 [40] vs 54 [42

67 ed nitric oxide to preterm infants requiring positive pressure respiratory support on postnatal days

68 n 1250 g receiving mechanical ventilation or positive pressure respiratory support on postnatal days

69 The fluorescence images suggest that a positive pressure results in compression of the bilayer

70 and the flexible interface creates pulses of positive pressure rises, increase in temperature, stream

71 t (RS) (receiving supplemental oxygen and/or positive-pressure RS); among those, oxygen/RS at 36 week

72 The presented method uses a positive-pressure sampling chamber and membrane filters

73 low the transition, followed by a hardening (positive pressure shift) above it.

74 Such positive pressures should be tried in order to encourage

75 a (MCC)-13 cells; piezo2 is a low-threshold, positive pressure-specific, curvature-sensitive, mechani

76 ebo until they no longer required oxygen and positive-pressure support or until they reached a postme

77 Noninvasive positive pressure techniques such as continuous and bile

78 indoor air measured during the negative and positive pressure test conditions was sufficient to dete

79 At positive pressure, the LMkappaT has escaped observation

80 d trials do not currently support a role for positive pressure therapies for reducing cardiovascular

81 Application of positive pressure through the patch pipette separated th

82 gion of the outer leaflet and increasing the positive pressure throughout the hydrocarbon core.

83 protective ventilation and an end-expiratory positive pressure titrated to a plateau pressure of 28-3

84 Application of positive pressure to cell-attached macropatch electrodes

85 ery were substantially increased by applying positive pressure to the patch electrode evoking membran

86 o "idle" at the genome end and to maintain a positive pressure towards the packaged state.

87 bitory influence of ACMV at increased VT and positive pressure upon the amplitude of respiratory moto

88 6 minutes at 100 compressions per minute and positive pressure ventilation (100% O2) with a compressi

89 th RSV were associated with a greater use of positive pressure ventilation (4074 [29.7%] vs 18 821 [1

90 ho progressed to acute lung injury requiring positive pressure ventilation (area under the receiver-o

91 eas the use of oxygen (from 33.6% to 29.3%), positive pressure ventilation (from 10.8% to 7.9%), and

92 with higher severity, defined by the use of positive pressure ventilation (i.e., continuous positive

93 these patients had not received inspiratory positive pressure ventilation (IPPV) despite having had

94 of conversion from conventional intermittent positive pressure ventilation (IPPV) to cuirass negative

95 of prolonged HFOV with low tidal volume (VT) positive pressure ventilation (LV-PPV) in an immature ba

96 Although noninvasive positive pressure ventilation (NIPPV) for patients with

97 The association of home noninvasive positive pressure ventilation (NIPPV) with outcomes in c

98 tal oxygen, 7618 (9.4%) required noninvasive positive pressure ventilation (NIPPV), and 3673 (4.6%) r

99 Although noninvasive positive pressure ventilation (NPPV) is a widely accepte

100 Noninvasive positive pressure ventilation (NPPV) is usually applied

101 We used noninvasive positive pressure ventilation (NPPV) with a helmet-type

102 ly treated by using intermittent noninvasive positive pressure ventilation (NPPV).

103 ntial of spontaneous breathing effort during positive pressure ventilation (PPV) in adults is well-un

104 Modern clinical devices utilizing positive pressure ventilation (PPV) may overdistend lung

105 pids with bronchiolitis severity, defined by positive pressure ventilation (PPV) use.

106 with more-severe disease, defined by use of positive pressure ventilation (PPV), in infants hospital

107 to have required oxygen supplementation and positive pressure ventilation after birth than nonasthma

108 Of 1,016 infants, 5.4% underwent positive pressure ventilation and 16.0% had intensive tr

109 lmonary dysplasia between nasal intermittent positive pressure ventilation and CPAP, both when used a

110 support, most importantly nasal intermittent positive pressure ventilation and high flow nasal cannul

111 dministration is related to short periods of positive pressure ventilation and implies the risk of lu

112 Invasive positive pressure ventilation and renal replacement ther

113 piratory distress syndrome prior to need for positive pressure ventilation are required so that these

114 us positive airway pressure and non-invasive positive pressure ventilation are safe and efficacious.

115 rgoing tracheal intubation with sedation and positive pressure ventilation at 11 intensive care units

116 = 4.7), history of bronchiolitis (OR = 4.7), positive pressure ventilation at birth (OR = 3.3), low m

117 oninvasive ventilation and administration of positive pressure ventilation between induction and lary

118 s defined by the acute onset of the need for positive pressure ventilation by an endotracheal or trac

119 orse 24-hr neurologic outcomes compared with positive pressure ventilation cardiopulmonary resuscitat

120 uration (%) were significantly higher in the positive pressure ventilation compared with the no assis

121 ays' gestation with bradycardia who received positive pressure ventilation during resuscitation after

122 Positive pressure ventilation exposes the lung to mechan

123 ve organ dysfunction (defined as: pulmonary, positive pressure ventilation for > 7 days; renal, incre

124 nt, and maintained on appropriate oxygen and positive pressure ventilation for at least 1 to 2 mo.

125 3, were intubated and initially managed with positive pressure ventilation for severe respiratory fai

126 ion pressure was significantly higher in the positive pressure ventilation group (33 +/- 15 vs. 14 +/

127 Paco2 was significantly lower in the positive pressure ventilation group (48 +/- 10 vs. 77 +/

128 rbations are becoming known, and noninvasive positive pressure ventilation has become an option for p

129 The uptake of noninvasive positive pressure ventilation has resulted in widespread

130 Both heliox and bilevel positive pressure ventilation have demonstrated clinical

131 Goal targets to achieve lung aeration during positive pressure ventilation have not been established

132 ment may reduce lung parenchymal injury from positive pressure ventilation in ARDS.

133 ous positive airway pressure and noninvasive positive pressure ventilation in children with sleep-dis

134 ous positive airway pressure and noninvasive positive pressure ventilation in nonresponders has becom

135 I evidence supporting the use of noninvasive positive pressure ventilation in such critical care sett

136 ll designed studies suggest that noninvasive positive pressure ventilation is not an appropriate inte

137 Noninvasive positive pressure ventilation may be considered a first

138 CPAP with surfactant but without any positive pressure ventilation may work synergistically.

139 respirator was switched over to non-invasive positive pressure ventilation on 24th day.

140 terobserver variability was not explained by positive pressure ventilation or by the presence of (> 4

141 either promote lung healing and weaning from positive pressure ventilation or delay recovery because

142 supported with nasally delivered noninvasive positive pressure ventilation or high-flow nasal cannula

143 For the positive pressure ventilation outcome, machine learning

144 ive of seven alive and neurologically intact positive pressure ventilation pigs with a cerebral perfo

145 s with triggering and cycling of noninvasive positive pressure ventilation remain an issue in small o

146 15, they also 1) applied oxygen but deferred positive pressure ventilation several minutes, 2) solidi

147 ompelling, but evidence favors a noninvasive positive pressure ventilation trial.

148 The outcomes were positive pressure ventilation use and intensive treatmen

149 2.8%-0.1%) reduction per year in noninvasive positive pressure ventilation use compared with the ICU-

150 ficantly enriched subpathway in infants with positive pressure ventilation use compared with those wi

151 ent (admission to intensive care unit and/or positive pressure ventilation use).

152 s are significantly associated with risks of positive pressure ventilation use, including the host-ty

153 uous positive airway pressure or noninvasive positive pressure ventilation use.

154 eived continuous positive airway pressure or positive pressure ventilation via face mask and were ran

155 jury criteria to acute lung injury requiring positive pressure ventilation was 20 hours.

156 Nasal intermittent positive pressure ventilation was superior to continuous

157 ommended in 22% of patients; and noninvasive positive pressure ventilation was used by only 21% of pa

158 Association of home noninvasive positive pressure ventilation with clinical outcomes in

159 Combining positive pressure ventilation with diaphragm neurostimul

160 Positive pressure ventilation with large VTs has been sh

161 sitive pressure ventilation; b) intermittent positive pressure ventilation with tracheal insufflation

162 ositioned at the carina; and c) intermittent positive pressure ventilation with tracheal insufflation

163 lium-oxygen therapy (heliox), or noninvasive positive pressure ventilation within 24 hrs of extubatio

164 ring hospitalization (eg, inotropic support, positive pressure ventilation), diagnoses indicating sev

165 rtile versus 15% for the others; noninvasive positive pressure ventilation, 8% versus 19%; vasopresso

166 liox gaseous mixture and noninvasive bilevel positive pressure ventilation, are being utilized in the

167 ons, chest radiography, supplemental oxygen, positive pressure ventilation, central venous catheter,

168 or until the time of intubation, noninvasive positive pressure ventilation, high-flow nasal cannula,

169 ive airway pressure for 10 to 30 minutes and positive pressure ventilation, if needed, with the rando

170 er therapies for ARDS, including noninvasive positive pressure ventilation, inverse ratio ventilation

171 ventilator-induced lung injury (VILI) during positive pressure ventilation, mechanisms of normal alve

172 (2) high-flow nasal cannula, (3) noninvasive positive pressure ventilation, or (4) invasive mechanica

173 or more via nonrebreather mask, noninvasive positive pressure ventilation, or high-flow nasal cannul

174 s rapidly developed requiring high levels of positive pressure ventilation.

175 pulmonary resuscitation (CPR) while allowing positive pressure ventilation.

176 design on CO2 rebreathing during noninvasive positive pressure ventilation.

177 ient's inspiratory effort during noninvasive positive pressure ventilation.

178 the lung damage associated with conventional positive pressure ventilation.

179 ary artery pressures in the absence of tidal positive pressure ventilation.

180 opulmonary bypass, aortic cross-clamping and positive pressure ventilation.

181 as instilled into the lung while maintaining positive pressure ventilation.

182 start of new treatments such as non-invasive positive pressure ventilation.

183 enuate the drop in cardiac output induced by positive pressure ventilation.

184 spiratory support escalation, and receipt of positive pressure ventilation.

185 d specificity (86%) in predicting the use of positive pressure ventilation.

186 ients with lung injury prior to the need for positive pressure ventilation.

187 ssed to acute lung injury prior to requiring positive pressure ventilation.

188 %) progressed to acute lung injury requiring positive pressure ventilation.

189 ventilated by three methods: a) intermittent positive pressure ventilation; b) intermittent positive

190 rgical airway condition; chronic noninvasive positive pressure ventilation; the need to replace the e

191 < 0.001), with increased use of noninvasive positive-pressure ventilation (5% in 1998 to 14% in 2010

192 ), animals were randomized into intermittent positive-pressure ventilation (control group), bilevel,

193 ventilation or high-flow oxygen/noninvasive positive-pressure ventilation (HR, 0.73; 95% CI: .53-1.0

194 Intermittent positive-pressure ventilation (IPPV) is the "gold standa

195 sive respiratory support--nasal intermittent positive-pressure ventilation (IPPV) or nasal continuous

196 of assisted ventilation, nasal intermittent positive-pressure ventilation (NIPPV) and synchronized i

197 igh-flow nasal cannula (HFNC) or noninvasive positive-pressure ventilation (NIPPV) or both were used

198 The patterns and outcomes of noninvasive, positive-pressure ventilation (NIPPV) use in patients ho

199 Noninvasive positive-pressure ventilation (NPPV) has been shown to b

200 Noninvasive positive-pressure ventilation (NPPV) is increasingly use

201 We compared noninvasive positive-pressure ventilation (NPPV), using bilevel posi

202 f a perfluorocarbon liquid during continuous positive-pressure ventilation (partial liquid ventilatio

203 ontinued debate regarding the equivalency of positive-pressure ventilation (PPV) and negative-pressur

204 Positive-pressure ventilation (versus oxygen/room air) w

205 pressure [CPAP] or noninvasive intermittent positive-pressure ventilation [NIPPV]) appears to be of

206 diac output was measured during intermittent positive-pressure ventilation and after 15 minutes of ne

207 Both intermittent positive-pressure ventilation and bilevel provided simil

208 auses induced by means of a step increase in positive-pressure ventilation applied via a face mask.

209 itive airway pressure and nasal intermittent positive-pressure ventilation as the main factors in the

210 and term infants; devices for administering positive-pressure ventilation at birth; family presence

211 n the vitamin C arm among patients requiring positive-pressure ventilation at the time of enrollment

212 e (Leycom) were measured over 8 intermittent positive-pressure ventilation breaths at tidal volume of

213 outcomes after continuous compressions with positive-pressure ventilation differed from those after

214 fied high-flow nasal cannula and noninvasive positive-pressure ventilation do not increase aerosol ge

215 benefit of jet ventilation over conventional positive-pressure ventilation during heart failure.

216 evices and interfaces used for administering positive-pressure ventilation during resuscitation of ne

217 rve pacemaker (PNP) and the reinstitution of positive-pressure ventilation for 8 mo.

218 ecially in severe patients, and non-invasive positive-pressure ventilation for treatment of acute ven

219 ositive airway pressure if breathing well or positive-pressure ventilation if not, with cord clamping

220 Role of noninvasive positive-pressure ventilation in acute lung injury/ARDS

221 h as high-flow nasal cannula and noninvasive positive-pressure ventilation is a concern for healthcar

222 demonstrate explicitly that lower-frequency positive-pressure ventilation not only preserves adequat

223 ndomized to the intervention received either positive-pressure ventilation or continuous positive air

224 stroke volume variation during intermittent positive-pressure ventilation predict preload responsive

225 , we randomly assigned neonates who required positive-pressure ventilation to be treated by a midwife

226 Whether positive-pressure ventilation with a bag-mask device (ba

227 el, 261 (109/386) (p = 0.195 vs intermittent positive-pressure ventilation) and 236 (86/364) (p = 0.8

228 ation, 28 (27/32) (p = 0.001 vs intermittent positive-pressure ventilation) and 26 (18/29) (p = 0.004

229 32.7 (30.4/33.4) (p = 0.021 vs intermittent positive-pressure ventilation) and 27.0 (24.5/27.7) (p =

230 29.1 (25.6/37.1) (p = 0.574 vs intermittent positive-pressure ventilation) and 28.7 (24.2/36.5) (p =

231 level, 39 (35/41) (p = 0.574 vs intermittent positive-pressure ventilation) and 46 (42/49) (p = 0.798

232 on, 598 (471/650) (p < 0.001 vs intermittent positive-pressure ventilation) and 634 (115/693) (p = 0.

233 7.35 (7.29/7.37) (p = 0.645 vs intermittent positive-pressure ventilation) and 7.27 (7.17/7.31) (p =

234 7.34 (7.33/7.39) (p = 0.189 vs intermittent positive-pressure ventilation) and 7.35 (7.34/7.36) (p =

235 was achieved in five of eight (intermittent positive-pressure ventilation), six of eight (bilevel),

236 7.35 (7.34/7.36) (p = 0.006 vs intermittent positive-pressure ventilation).

237 27.0 (24.5/27.7) (p = 0.779 vs intermittent positive-pressure ventilation).

238 and 236 (86/364) (p = 0.878 vs intermittent positive-pressure ventilation); and chest compression sy

239 7.27 (7.17/7.31) (p = 0.645 vs intermittent positive-pressure ventilation); and chest compression sy

240 28.7 (24.2/36.5) (p = 0.721 vs intermittent positive-pressure ventilation); and chest compression sy

241 and 634 (115/693) (p = 0.054 vs intermittent positive-pressure ventilation); PaCO2 intermittent posit

242 es (torr) were as follows: PaO2 intermittent positive-pressure ventilation, 143 (76/256) and 262 (81/

243 inutes (mm Hg) were as follows: intermittent positive-pressure ventilation, 28.0 (25.0/29.6) and 27.9

244 ve-pressure ventilation); PaCO2 intermittent positive-pressure ventilation, 40 (38/43) and 45 (36/52)

245 9) (p = 0.004); mixed venous pH intermittent positive-pressure ventilation, 7.34 (7.31/7.35) and 7.26

246 re admitted to intensive care, 26.4% had new positive-pressure ventilation, and 19.7% received vasopr

247 milking, device selection for administering positive-pressure ventilation, and an additional primary

248 y ventilated with volume-cycled intermittent positive-pressure ventilation, and negative-pressure ven

249 e investigated the influence of intermittent positive-pressure ventilation, bilevel ventilation, and

250 >24 hours, septic shock, vasoactive agents, positive-pressure ventilation, chest drainage, extracorp

251 >24 hours, septic shock, vasoactive agents, positive-pressure ventilation, chest drainage, extracorp

252 luid, sustained inflations for initiation of positive-pressure ventilation, initial oxygen concentrat

253 y pressure (PEEP) valve, noninvasive bilevel positive-pressure ventilation, nonrebreather face masks,

254 If up to 5% receive positive-pressure ventilation, this evidence evaluation

255 ied high-flow nasal cannula, and noninvasive positive-pressure ventilation.

256 rest and decreased requirement for immediate positive-pressure ventilation.

257 stroke volume variation during intermittent positive-pressure ventilation.

258 hodilators, corticosteroids, and noninvasive positive-pressure ventilation.

259 All were sedated and paralyzed and received positive-pressure ventilation.

260 ified high-flow nasal cannula or noninvasive positive-pressure ventilation.

261 vs 19 patients (7.8%) receiving noninvasive positive-pressure ventilation.

262 ditional primary interface for administering positive-pressure ventilation.

263 elivered through a face mask, or noninvasive positive-pressure ventilation.

264 with an inspiratory threshold valve between positive pressure ventilations.

265 either no assisted ventilation (n = 9) or 10 positive pressure ventilations/min (Smart Resuscitator B

266 The dogs were ventilated using a positive-pressure ventilator driven by phrenic neural ac

267 Likewise, the minute volume of positive pressure ventilatory support should be limited

268 The average percentage of time in which a positive pressure was recorded in the lungs was 47.3 +/-

269 ed cheek, creating a closed air column under positive pressure with resultant surrounding soft-tissue

270 provides a rapid way for measuring the peak positive pressure, without the scan time, which is requi